BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34726201)

  • 21. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
    Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
    Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan.
    Hayama M; Maeda Y; Shikina T; Tatehara S; Inokuchi G; Hoag JB; Sato T; Obata S; Nakatani A; Amano Y; Hida E; Nibu KI; Inohara H
    Auris Nasus Larynx; 2022 Jun; 49(3):415-420. PubMed ID: 34857410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis.
    Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S
    Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia.
    Fiorella ML; Lillo L; Fiorella R
    Acta Otorhinolaryngol Ital; 2012 Jun; 32(3):164-9. PubMed ID: 22767981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
    Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
    Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal Endoscopy in the Clinical Diagnosis of Hereditary Hemorrhagic Telangiectasia.
    Matti E; Lizzio R; Ugolini S; Maiorano E; Zaccari D; De Silvestri A; De Sando E; Marseglia GL; Benazzo M; Olivieri C; Pagella F; Spinozzi G
    J Pediatr; 2021 Nov; 238():74-79.e2. PubMed ID: 34265342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.
    Jiang Y; Dennis SC; Brewin MP
    Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of two grading systems for epistaxis in hereditary haemorrhagic telangiectasia.
    Jorgensen OJ; Steineger J; Bachmann-Harildstad G; Dheyauldeen S
    Rhinology; 2021 Apr; 59(2):212-218. PubMed ID: 33821857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.
    Folz BJ; Wollstein AC; Lippert BM; Werner JA
    Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Luk L; Mace JC; Bhandarkar ND; Sautter NB
    Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure.
    Bruschini L; Seccia V; Dallan I
    Am J Otolaryngol; 2011; 32(4):301-3. PubMed ID: 20719406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States.
    Brinjikji W; Wood CP; Lanzino G; Cloft HJ; Misra S; Kallmes DF; Kamath P; Pruthi RK; Krowka MJ; Swanson KL; Iyer VN
    Ann Am Thorac Soc; 2016 Sep; 13(9):1505-11. PubMed ID: 27387823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
    Woodard TD; Yappel-Sinkko KB; Wang X; McCrae KR; Parambil JG
    Laryngoscope; 2022 May; 132(5):920-925. PubMed ID: 34160081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
    Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
    Otolaryngol Head Neck Surg; 2020 Jan; 162(1):8-25. PubMed ID: 31910122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of anterior palatine blocks on bleeding in hereditary hemorrhagic telangiectasia nasal surgery.
    Guthrie CC; Karnezis TT; Orosco RK; Bishop ML; Davidson TM
    Laryngoscope; 2013 Nov; 123(11):2598-600. PubMed ID: 23670536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis.
    Esteban-Casado S; Martín de Rosales Cabrera AM; Usarralde Pérez A; Martínez Simón JJ; Zhan Zhou E; Marcos Salazar MS; Pérez Encinas M; Botella Cubells L
    Laryngoscope; 2019 Oct; 129(10):2216-2223. PubMed ID: 30908653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxis.
    Ingrand I; Ingrand P; Gilbert-Dussardier B; Defossez G; Jouhet V; Migeot V; Dufour X; Klossek JM
    Rhinology; 2011 Jun; 49(2):155-62. PubMed ID: 21743869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.